Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Proceedings of the National Academy of Sciences

Topics

Biology

Immunology

Infectious Diseases

Molecular Biology

Virology

Show all topics

DOI

10.1073/pnas.2311752120

License

CC-BY-NC-ND

Other Formats

PDF